​Raj Indupuri is a CEO and Co-Founder of eClinical Solutions, a technologist with significant industry experience, passionate about fostering innovation to revolutionize the Life Sciences industry with ground-breaking technologies that will modernize clinical trials and bring treatments to patients faster. Responsible for establishing eClinical Solutions vision and future-looking strategy, working with a talented and dedicated team to realize the digital future, enabling progress and maximizing potential with data and analytics at the core of the company’s innovative products and solutions. Firmly believes data is the new fuel that will drive human progress.

​Joris van Dam is a Data and Digital Health Leader with 20+ years of experience in life sciences. Earlier this year, Joris co-founded Advokare.health, a start-up that is on a mission to democratize evidence-based care with the help of AI. Prior to that, he built a clinicogenomic platform of 12+Mio cancer patients at Exact Sciences, led the Digital Therapeutics program at Novartis, launched a mobile platform for community-based heart-health screening of underserved populations in Zambia, founded a real-world data and analytics company, and led the development of a digital health platform supporting HIV patients in India. Joris holds a PhD in Artificial Intelligence from the University of Amsterdam.

​Eli Goldberg, PhD, is an accomplished data science leader, entrepreneur, and core angel investor. He is a core angel with Springboard Health Angels, a Berlin-based investment and venture fund, and the founder of Goldberg Consulting LLC (GC LLC), which supports life science and payer industries with clients including BMS and PwC. Previously, he served as VP of Data Science at Current Health, which was acquired by Best Buy Health for $400M. His experience includes senior roles in clinical analytics at CVS Aetna, scientific intrapreneurship at Novartis, and founding several healthcare startups. He also serves on scientific advisory boards in the US and Australia and holds advanced degrees from ETH Zurich.

Shobi Ahmed, MD, PhD, is a physician-scientist and historian-anthropologist working at the intersection of precision medicine, artificial intelligence, and neurotechnology. Shobi is the founder and CEO of Sama Therapeutics, which seeks to transform outcomes in both routine care and clinical trials for complex patients — synthesizing more objective, generative AI-powered biomarkers to eliminate trial-and-error — beginning with neuropsychiatry. In the last three years, Sama’s team has been leveraging a massively multimodal approach and cross-disciplinary skillset across systems biology and machine learning to push the boundaries of biomedical innovation.

Previously, Shobi led pre/clinical development pipelines, trained in pediatric critical care, and triangulated multiomics+natural language processing for drug discovery with pharmaceutical R&D partners. He studied immuno-oncology, medical anthropology, and ancient blasphemy/heresy law as an MD/PhD student at Yale and Harvard, and holds BS/BA degrees in biomedical engineering and history of science/philosophy from Johns Hopkins University.

Michelle Higginson, MBA, is a seasoned operator and marketing leader with nearly two decades of experience spanning technology and healthcare. She helped propel LogMeIn into the ranks of top global SaaS companies, led award-winning campaigns at Boston Children’s Hospital, and drove growth at HBS-founded Avant-garde Health before co-founding Inlightened, the only healthcare insights company prioritizing diversity, technology, and transparency. Michelle is a graduate and post-graduate of Bentley University, and serves on the board of Easterseals Massachusetts.

Moderator – Amir Lahav is the founder of SkyMedAI. He is also a Clinical Scientist, Strategic Advisor, and Global Thought Leader at the forefront of Digital Health, Artificial Intelligence, and Modern Medicine. He is the curator and scientific director of the DHAI Summit. Amir sits on the advisory board of multiple medtech startups and holds strategic consulting roles with leading pharmaceutical companies. During his time at Pfizer, he led the development of wearable tech and remote monitoring solutions for gene therapy trials, primarily in rare diseases. Prior to pharma, he was a PI on numerous clinical trials as a Neurology Faculty and Professor of Pediatrics at Harvard Medical School.

Peter Micca, Venture Partner

Senior Partner, Life Sciences and Healthcare, Deloitte and Touche, LLP

Peter Micca has over 30 years of experience with a global professional services firm advising a broad array of organizations in all sectors of the healthcare, technology, and life sciences industries, including significant experience with emerging growth private equity, venture capital, and strategic investor-financed companies. Peter brings practical, in-depth knowledge of industry business issues and emerging trends surrounding consumerism, convergence, cost considerations, regulatory and compliance issues, and consolidation.

In his current role, Peter leads the development of national strategy, including client service, quality, business development, marketing, and eminence, with organizations developing innovative and disruptive technology and services to the industry.

Peter has served in various advisory roles with several prominent domestic and global industry organizations, including Columbia Business School Digital Health Innovation Program, the New York University Endless Frontier Labs, the advisory boards of St. John’s University, Tobin College of Business, and School of Pharmacy and Health Sciences, and the Digital Health Innovation Summit. Peter is a graduate of St. John’s University, The Peter J. Tobin College of Business, with an M.S. in Accounting and Finance.

Based in Astoria, NYC, Bailey Morgan is a versatile healthtech leader who merges clinical expertise with business acumen to accelerate healthcare innovation and community impact. Having started her career as a medical speech language pathologist working within inpatient facilities throughout the boroughs of NYC, she saw firsthand how behind the healthcare tech ecosystem was compared to industries such as tech or finance.

After leaving healthcare to move into the healthtech startup space, Bailey has since raised over $10M in capital, led several successful sales and marketing teams through go-to-market stages in both SaaS and CPG, and has closed over $2M in technology sales herself. She currently serves as Chief of Staff at Groth Pain & Spine, a pain management practice with 10+ locations and 40+ providers, where she leads the change management and technology integrations for the practices acquisitions.

In addition to consulting with various healthcare technology companies, Bailey is a Director and the Treasurer for an NYC-based dementia-focused nonprofit that employs individuals living with dementia and supports families and caregivers.

Director and Founder of a company specializing in Data Integrity solutions, helping organizations efficiently meet regulatory requirements.

An accomplished technological and operational leader with more than 16 years of experience dreaming and building new healthcare and life science technology solutions, leading highly complex projects in a clinical regulatory environment, accelerating innovation, implementing noble work processes, while developing high-performance teams.